在CAR-T细胞治疗淋巴瘤之前的桥梁放射治疗期间和之后的治疗动力学和局部反应

Daniella Klebaner1, Natalie J Park1, Mallika Marar1

  • 1Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, USA.

Leukemia & lymphoma
|December 26, 2025
PubMed
概括

在非霍奇金淋巴瘤的CAR-T疗法之前进行过桥式放射治疗可能会改善结果. 通过体积减少定义的快速桥梁反应与复发/耐药淋巴瘤患者局部进展风险较低有关.

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K